These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 7014587

  • 21. Dopaminergic modulation of pressor and hormonal responses in essential hypertension.
    Sowers JR, Golub MS, Berger ME, Whitfield LA.
    Hypertension; 1982; 4(3):424-30. PubMed ID: 6279498
    [Abstract] [Full Text] [Related]

  • 22. Role of prolactin and the renin-angiotensin system in mediating dopaminergic control of aldosterone secretion in the rat.
    Sowers JR, Golub M, Tuck M, Sowers DK.
    Clin Exp Hypertens (1978); 1981; 3(1):1-14. PubMed ID: 7472089
    [Abstract] [Full Text] [Related]

  • 23. Modulation of corticosteroid secretion by dopaminergic mechanisms in rhesus monkeys.
    Sowers JR.
    Am J Physiol; 1982 Nov; 243(5):E375-9. PubMed ID: 7137342
    [Abstract] [Full Text] [Related]

  • 24. Dopaminergic control of 18-hydroxycorticosterone responses to posture, isometric exercise, and diuretic administration in normal man.
    Sowers JR, Martin VI, Stern N, Berg G.
    J Clin Endocrinol Metab; 1982 Sep; 55(3):475-80. PubMed ID: 7096536
    [Abstract] [Full Text] [Related]

  • 25. Dopaminergic control of plasma catecholamine and aldosterone responses to acute stimuli in normal man.
    Whitfield L, Sowers JR, Tuck ML, Golub MS.
    J Clin Endocrinol Metab; 1980 Oct; 51(4):724-9. PubMed ID: 6252224
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Dopaminergic blockade of the renin-angiotensin-aldosterone system: effect of high and low sodium intakes.
    Gordon MB, Moore TJ, Dluhy RG, Williams GH.
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):415-25. PubMed ID: 6354522
    [Abstract] [Full Text] [Related]

  • 29. Acute dopaminergic inhibition of aldosterone secretion is independent of angiotensin II and adrenocorticotropin.
    Carey RM.
    J Clin Endocrinol Metab; 1982 Feb; 54(2):463-9. PubMed ID: 6274907
    [Abstract] [Full Text] [Related]

  • 30. Dopaminergic modulation of aldosterone responsiveness to angiotensin II with changes in sodium intake.
    Gordon MB, Moore TJ, Dluhy RG, Williams GH.
    J Clin Endocrinol Metab; 1983 Feb; 56(2):340-5. PubMed ID: 6822640
    [Abstract] [Full Text] [Related]

  • 31. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA, De'Oliveira JM, Fisher ND, Williams GH, Hollenberg NK.
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [Abstract] [Full Text] [Related]

  • 32. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
    Sowers JR, Beck FW.
    Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674
    [Abstract] [Full Text] [Related]

  • 33. Pressor and hormonal responses to intravenous injection of metoclopramide in normotensive and hypertensive patients.
    Kawabe H, Suzuki H, Itaya Y, Saruta T.
    Jpn J Med; 1990 Feb; 29(2):174-9. PubMed ID: 2232366
    [Abstract] [Full Text] [Related]

  • 34. Dopaminergic modulation of aldosterone secretion in the rat.
    Aguilera G, Catt KJ.
    Endocrinology; 1984 Jan; 114(1):176-81. PubMed ID: 6317344
    [Abstract] [Full Text] [Related]

  • 35. The effect of metoclopramide and dopamine on plasma aldosterone concentration in normal man and rhesus monkeys (Macaca mulatta): a new model to study dopamine control of aldosterone secretion.
    Brown RD, Billman GE, Kem DC, Stone HL, Jiang NS, Kao P, Hegstad RL.
    J Clin Endocrinol Metab; 1982 Nov; 55(5):828-32. PubMed ID: 7119085
    [Abstract] [Full Text] [Related]

  • 36. Aldosterone and renin-angiotensin responses to stimuli in patients with treated congestive heart failure.
    Nicholls MG, Espiner EA, Donald RA.
    J Lab Clin Med; 1976 Jun; 87(6):1005-15. PubMed ID: 180213
    [Abstract] [Full Text] [Related]

  • 37. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
    Mizuno K, Yamazaki M, Ikeda K, Yaginuma K, Hashimoto S, Fukuchi S.
    Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
    [Abstract] [Full Text] [Related]

  • 38. Influence of sodium homeostasis and circadian rhythm on dopaminergic modulation of 18-hydroxycorticosterone secretion in man.
    Sowers JR, Stern N.
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1046-51. PubMed ID: 7130335
    [Abstract] [Full Text] [Related]

  • 39. Prolactin and calcitonin responses to parathyroid hormone infusion in hypoparathyroid, pseudohypoparathyroid, and normal subjects.
    Brickman AS, Carlson HE, Deftos LJ.
    J Clin Endocrinol Metab; 1981 Sep; 53(3):661-4. PubMed ID: 7263847
    [Abstract] [Full Text] [Related]

  • 40. A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion.
    Demura R, Naruse M, Isawa M, Onoda N, Naruse K, Yamakado M, Demura H.
    Endocrinol Jpn; 1992 Apr; 39(2):169-76. PubMed ID: 1396349
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.